MX2022016174A - Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. - Google Patents
Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.Info
- Publication number
- MX2022016174A MX2022016174A MX2022016174A MX2022016174A MX2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A
- Authority
- MX
- Mexico
- Prior art keywords
- compulsive disorder
- compositions
- methods
- treating obsessive
- obsessive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063043681P | 2020-06-24 | 2020-06-24 | |
| PCT/US2021/038789 WO2021262914A1 (en) | 2020-06-24 | 2021-06-24 | Compositions and methods for treating obsessive-compulsive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022016174A true MX2022016174A (es) | 2023-01-24 |
Family
ID=79281806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022016174A MX2022016174A (es) | 2020-06-24 | 2021-06-24 | Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230181541A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4171554A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7805969B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230027189A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115968312A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021297249A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022025901A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3187323A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299301A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022016174A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12022553441A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021262914A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP2400349A1 (hu) * | 2024-07-05 | 2026-01-28 | Egis Gyógyszergyár Zrt. | Troriluzole-hidroklorid-sók |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2819303T3 (es) | 2005-04-05 | 2021-04-15 | Univ Yale | Agentes moduladores del glutamato en el tratamiento de trastornos mentales |
| DK3265448T3 (da) | 2015-03-03 | 2022-03-28 | Biohaven Therapeutics Ltd | Riluzol-prodrugs og anvendelse deraf |
| DK3297619T3 (da) | 2015-05-22 | 2022-08-15 | Vistagen Therapeutics Inc | Terapeutiske anvendelser af L-4-chlorkynurenin |
| US10751345B2 (en) | 2018-02-21 | 2020-08-25 | AI Therapeutics, Inc. | Combination therapy with apilimod and glutamatergic agents |
| CN112203692A (zh) | 2018-05-27 | 2021-01-08 | 拜尔哈文制药股份有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
| JP2021530543A (ja) | 2018-07-22 | 2021-11-11 | バイオヘイブン・セラピューティクス・リミテッドBiohaven Therapeutics Ltd. | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
| CN112584831A (zh) | 2018-08-16 | 2021-03-30 | 拜奥海芬治疗学有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
-
2021
- 2021-06-24 IL IL299301A patent/IL299301A/en unknown
- 2021-06-24 MX MX2022016174A patent/MX2022016174A/es unknown
- 2021-06-24 BR BR112022025901A patent/BR112022025901A2/pt unknown
- 2021-06-24 KR KR1020237001813A patent/KR20230027189A/ko active Pending
- 2021-06-24 PH PH1/2022/553441A patent/PH12022553441A1/en unknown
- 2021-06-24 AU AU2021297249A patent/AU2021297249A1/en active Pending
- 2021-06-24 EP EP21829058.3A patent/EP4171554A4/en active Pending
- 2021-06-24 CA CA3187323A patent/CA3187323A1/en active Pending
- 2021-06-24 US US17/923,587 patent/US20230181541A1/en active Pending
- 2021-06-24 JP JP2022578616A patent/JP7805969B2/ja active Active
- 2021-06-24 CN CN202180044180.1A patent/CN115968312A/zh active Pending
- 2021-06-24 WO PCT/US2021/038789 patent/WO2021262914A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN115968312A (zh) | 2023-04-14 |
| KR20230027189A (ko) | 2023-02-27 |
| PH12022553441A1 (en) | 2024-03-04 |
| EP4171554A1 (en) | 2023-05-03 |
| JP2023531919A (ja) | 2023-07-26 |
| JP7805969B2 (ja) | 2026-01-26 |
| AU2021297249A1 (en) | 2023-02-23 |
| CA3187323A1 (en) | 2021-12-30 |
| BR112022025901A2 (pt) | 2023-01-10 |
| IL299301A (en) | 2023-02-01 |
| WO2021262914A1 (en) | 2021-12-30 |
| US20230181541A1 (en) | 2023-06-15 |
| EP4171554A4 (en) | 2024-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| NZ630367A (en) | Methods of treatment of pediatric solid tumor | |
| MX2024014121A (es) | Metodos y composiciones para el tratamiento del exceso de glucocorticoides | |
| AU2018282105A1 (en) | Dosing of vibegron for treatment of overactive bladder | |
| WO2022010813A3 (en) | Enhancing immune responses through targeted antigen expression | |
| MX2023003723A (es) | Anticuerpos anti-il-36r para el tratamiento de dolor inflamatorio cronico. | |
| MX2020007817A (es) | Prevención y tratamiento del trastorno del sueño. | |
| PH12022553441A1 (en) | Compositions and methods for treating obsessive-compulsive disorder | |
| MX2020007222A (es) | Metodos para el tratamiento de afecciones inflamatorias de la piel. | |
| MX2023001233A (es) | Metodos de tratamiento del cancer positivo para her2 con tucatinib en combinacion con trastuzumab, un taxano y un antagonista del vegfr-2. | |
| MY200247A (en) | Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors | |
| PH12021553055A1 (en) | Methods and compositions for improving outcomes of cancer patients | |
| MX2023006704A (es) | Composiciones dsg2 y metodos para el tratamiento de covid-19. | |
| PH12021551975A1 (en) | Use of vibegron to treat overactive bladder | |
| MX2025006987A (es) | Metodos para aumentar el bienestar mental y/o la felicidad | |
| MX2023009620A (es) | Metodos terapeuticos. | |
| MX2025000682A (es) | Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma | |
| MX2023000151A (es) | Terapia de combinacion de verapamilo y mometasona para el tratamiento de rinosinusitis cronica. | |
| EP4467131A3 (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| MX2023008876A (es) | Tratamiento de la apnea del sueño con cannabidiol (cbd). | |
| CR20230190A (es) | Compuesto degradante en un medicamento | |
| MX2023008796A (es) | Métodos para el tratamiento del trastorno del habla en niños. | |
| ZA202202673B (en) | Methods and compositions for treating endometriosis | |
| MX2024002602A (es) | Métodos para prevenir y tratar el dolor y síntomas asociados. |